These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
77 related articles for article (PubMed ID: 1313266)
1. Comparative studies on cyclic nucleotide phosphodiesterases and inhibitors in experimental models of hypertension, congestive heart failure, and allergic asthma. Silver PJ; Gordon RJ; Buchholz RA; Dundore RL; Ferguson EW; Harris AL; Pagani ED Adv Second Messenger Phosphoprotein Res; 1992; 25():341-51. PubMed ID: 1313266 [No Abstract] [Full Text] [Related]
2. Therapeutic potential of isozyme-selective phosphodiesterase inhibitors in the treatment of asthma. Torphy TJ; Livi GP; Balcarek JM; White JR; Chilton FH; Undem BJ Adv Second Messenger Phosphoprotein Res; 1992; 25():289-305. PubMed ID: 1372813 [No Abstract] [Full Text] [Related]
3. Prospects for selective cyclic nucleotide phosphodiesterase inhibitors in the treatment of bronchial asthma. Giembycz MA; Dent G Clin Exp Allergy; 1992 Mar; 22(3):337-44. PubMed ID: 1316796 [No Abstract] [Full Text] [Related]
4. Phosphodiesterases in vascular endothelial cells. Kishi Y; Ashikaga T; Numano F Adv Second Messenger Phosphoprotein Res; 1992; 25():201-13. PubMed ID: 1372811 [No Abstract] [Full Text] [Related]
5. Characterization of ORG 20241, a combined phosphodiesterase IV/III cyclic nucleotide phosphodiesterase inhibitor for asthma. Nicholson CD; Shahid M; Bruin J; Barron E; Spiers I; de Boer J; van Amsterdam RG; Zaagsma J; Kelly JJ; Dent G J Pharmacol Exp Ther; 1995 Aug; 274(2):678-87. PubMed ID: 7636728 [TBL] [Abstract][Full Text] [Related]
6. Primary sequence of cyclic nucleotide phosphodiesterase isozymes and the design of selective inhibitors. Beavo JA; Reifsnyder DH Trends Pharmacol Sci; 1990 Apr; 11(4):150-5. PubMed ID: 2159198 [TBL] [Abstract][Full Text] [Related]
7. Cyclic nucleotide phosphodiesterases in the circulatory system. Biochemical, pharmacological, and functional characteristics. Weishaar RE; Kobylarz-Singer D; Keiser JA; Wright CD; Cornicelli J; Panek R Adv Second Messenger Phosphoprotein Res; 1992; 25():249-69. PubMed ID: 1313261 [No Abstract] [Full Text] [Related]
8. Regional and developmental expression of calmodulin-dependent cyclic nucleotide phosphodiesterase in rat brain. Kincaid RL; Balaban CD; Billingsley ML Adv Second Messenger Phosphoprotein Res; 1992; 25():111-22. PubMed ID: 1313253 [No Abstract] [Full Text] [Related]
9. Pharmacological manipulation of tissue cyclic AMP by inhibitors. Effects of phosphodiesterase inhibitors on the functions of platelets and vascular endothelial cells. Tani T; Sakurai K; Kimura Y; Ishikawa T; Hidaka H Adv Second Messenger Phosphoprotein Res; 1992; 25():215-27. PubMed ID: 1372812 [No Abstract] [Full Text] [Related]
10. A histochemical method for demonstration of 2',3'-cyclic 3'-phosphohydrolase activity. Zaprianova E; Dikov A; Christova M; Kadiisky D Acta Histochem; 1983; 72(2):161-6. PubMed ID: 6308941 [TBL] [Abstract][Full Text] [Related]
11. Isozyme-selective cyclic nucleotide phosphodiesterase inhibitors: biochemistry, pharmacology and therapeutic potential in asthma. Raeburn D; Souness JE; Tomkinson A; Karlsson JA Prog Drug Res; 1993; 40():9-32. PubMed ID: 8395068 [No Abstract] [Full Text] [Related]
12. Differential modulation of tissue function and therapeutic potential of selective inhibitors of cyclic nucleotide phosphodiesterase isoenzymes. Nicholson CD; Challiss RA; Shahid M Trends Pharmacol Sci; 1991 Jan; 12(1):19-27. PubMed ID: 1848733 [TBL] [Abstract][Full Text] [Related]
14. [Changes in the proteins of the outer segments of retinal rods in rats with tapeto-retinal dystrophies]. Etingof RN; Ostapenko IA Vestn Akad Med Nauk SSSR; 1978; (10):3-8. PubMed ID: 212898 [No Abstract] [Full Text] [Related]
15. The effects of flavonoids on cyclic nucleotide phosphodiesterases. Beretz A; Anton R; Cazenave JP Prog Clin Biol Res; 1986; 213():281-96. PubMed ID: 3012580 [No Abstract] [Full Text] [Related]
16. Comparative structure-activity relationships for dihydropyridines as inhibitors of [3H]-nitrendipine binding vs cyclic nucleotide phosphodiesterases. Van Inwegen RG; Weinryb I; Jones H; Khandwala A Res Commun Chem Pathol Pharmacol; 1984 Aug; 45(2):191-206. PubMed ID: 6091198 [TBL] [Abstract][Full Text] [Related]
17. Vasodilator effects of nebivolol in a rat model of hypertension and a rabbit model of congestive heart failure. de Groot AA; Mathy MJ; van Zwieten PA; Peters SL J Cardiovasc Pharmacol; 2007 Jul; 50(1):56-60. PubMed ID: 17666916 [TBL] [Abstract][Full Text] [Related]
18. Simultaneous inhibition of guinea pig brain 2',3'-cyclic nucleotide 3'-phosphohydrolase and myelin protein synthesis by 2'-adenosine monophosphate. Starich GH; Dreiling CE Life Sci; 1980 Aug; 27(7):567-72. PubMed ID: 6252405 [No Abstract] [Full Text] [Related]
19. Enhanced activities and gene expression of phosphodiesterase types 3 and 4 in pressure-induced congestive heart failure. Takahashi K; Osanai T; Nakano T; Wakui M; Okumura K Heart Vessels; 2002 Sep; 16(6):249-56. PubMed ID: 12382034 [TBL] [Abstract][Full Text] [Related]
20. [Outer retinal rod segment cyclic nucleotide phosphodiesterase; protein inhibitor separation, bimodal effect of GTP]. Dumler IL; Furaev VV; Etingof RN Dokl Akad Nauk SSSR; 1980; 253(6):1504-8. PubMed ID: 6253254 [No Abstract] [Full Text] [Related] [Next] [New Search]